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We report the case of a female infant with Pfeiffer-like syndrome and holoprosen-
cephaly. She had a cloverleaf skull, ocular proptosis, broad thumbs and halluces, 
and variable accompanying anomalies compatible with Pfeiffer syndrome. She also 
displayed microcephaly, short palpebral fissures, and a smooth philtrum, which are 
clinical signs consistent with fetal alcohol syndrome. She suffered from multiple 
congenital anomalies and died at 41 days of age. Cardio-pulmonary failure, brain 
abnormalities, prematurity, and multiple complications contributed to her death. 
The patient displayed normal chromosomal numbers and type. DNA analysis did not 
reveal fibroblast growth factor receptor (FGFR) genes FGFR1, FGFR2, FGFR3 or TWIST 
gene mutations. We review the previous reports of Pfeiffer syndrome and holopros-
encephaly and describe our infant patient with Pfeiffer-like syndrome, holoprosen-
cephaly, and heavy in utero maternal alcohol and smoking exposures.
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1. Introduction
Craniosynostosis is the premature fusion of one or 
more cranial sutures. Its incidence at birth is 1:2100−
1:2500.1,2 Changes in head shape depend on the af-
fected sutures, and growth limitations are seen 
perpendicular to affected sutures. Cohen3 proposed 
three clinical Pfeiffer syndrome subtypes with di-
agnostic and prognostic implications. Type 1 is the 
“classic” Pfeiffer syndrome, as described by Pfeiffer.4 
The prognosis is good in the majority of cases with 
normal intelligence, and inheritance is autosomal 
dominant. Type 2 is characterized by a cloverleaf 
skull, severe ocular proptosis, elbow ankylosis, 
and hand and feet anomalies. Type 3 is the same 
phenotype as type 2, but affected individuals do 
not clinically demonstrate a cloverleaf skull. There 
is overlap between the three types,3 and the ma-
jority of patients have a poor clinical prognosis. 
The discovery of mutations in the fibroblast growth 
factor receptor (FGFR) genes FGFR1, FGFR2, and 
FGFR3 and in the helix-loop-helix transcription fac-
tor (TWIST1) gene, and their associated phenotypes 
have been reviewed elsewhere.5−7
FGFR1 and FGFR2 gene mutations have recently 
been identified in patients with Pfeiffer syn drome.8−11 
Several environmental factors have also been as-
sociated with isolated craniosynostosis. Ma ternal 
smoking,12 exposure to nitrosatable drugs,13 and 
general drugs during the prenatal period are known 
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to significantly increase the risk for craniosynosto-
sis. Male sex and parental education were also associ-
ated with sagittal craniosynostosis in another study.14
Holoprosencephaly is a developmental field de-
fect in impaired midline cleavage of the embryonic 
forebrain. The prosencephalon fails to cleave sag-
ittally into the cerebral hemispheres in alobar holo-
prosencephaly. It also fails to cleave transversely 
into the telencephalon and diencephalon, or hori-
zontally into the olfactory tracts and bulbs. Holo-
prosencephaly in humans is causally heterogeneous, 
pathogenetically variable, and has been extensively 
studied.15−22 Approximately 15−20% of holoprosen-
cephaly cases are due to genetic anomalies. Auto-
somal dominant monogenic inheritance has been 
reported with wide expressivity and incomplete 
penetrance15,23 in this condition.
Many teratology studies generated valuable in-
formation about holoprosencephaly in the 19th cen-
tury. Maternal alcohol consumption during early 
pregnancy was associated with holoprosencephaly 
in offspring.24 Another study reviewed 28 autopsies 
of individuals with holoprosencephaly with a history 
of alcohol abuse in one mother.4 Alcohol-induced 
holoprosencephaly has been reported in experi-
mental mice,25 pigtail macaques26 and zebrafish.27 
Addition ally, Rogers et al28 induced holoprosenceph-
aly in mice with methyl alcohol.
A study by Olney et al29 suggested that ethanol 
triggered massive apoptotic neurodegeneration in 
the developing brain by interfering with the gluta-
mate and gamma-amino butyric acid (GABA) neu-
rotransmitters at the N-methyl-d-aspartate and 
GABA/A receptors during synaptogenesis. This patho-
genesis can explain both the reduced brain mass 
and the neurobehavioral changes associated with 
fetal alcohol syndrome.
This report describes a case of Type 2 Pfeiffer 
syndrome in an infant.
2. Case Report
The female infant was the fourth child of healthy 
and non-consanguineous parents. The mother and 
father were 30 and 31 years old, respectively. Elder 
siblings were normal with no clinical concerns. The 
parents were asked about their cigarette and alcohol 
habits at the first clinical visit. The mother smoked 
approximately 20 cigarettes per day and both par-
ents drank approximately 200 mL of alcohol every 
1−2 days. The proposita was born at the gesta-
tional age of 35 weeks with a birth weight of 1450 g 
(< 10th percentile), length of 38.5 cm (< 10th per-
centile), and head circumference of 29.5 cm (10th 
percentile). Abnormalities included the presence of 
a cloverleaf skull, mild microcephaly, hypertelorism, 
ocular proptosis, short palpebral fissures, a broad 
nose, severe mid-face hypoplasia, marked lower 
set ears, a smooth philtrum, thin and smooth upper 
lip (Figure 1), cleft palate, micro gnathia, short neck, 
cubitus valgus, broad thumbs (Figure 2), altered 
palmar creases on both hands, broad and medially 
deviated halluces (Figure 3), and a talipes calca-
neovarus/varus skin dimple in the coccygeal area. 
Cranial and facial three-dimensional computed to-
mography revealed lobulated skull contours with a 
cloverleaf shape, complete premature sagittal and 
bilateral lambdoid suture closures, incomplete 
closure of the coronal sutures or triphyllocephaly 
(Figure 4), a highly arched cleft palate, bilateral 
choanal stenosis, bilateral external auditory canal 
bony atresia, and hypoplasia of stapes. Time-of-
flight magnetic resonance (MR) angiography with 
Figure 1 Physical examination revealed a cloverleaf 
skull, mild microcephaly, hypertelorism, ocular proptosis, 
short palpebral fissures, a broad nose, severe mid-face 
hypoplasia, marked lower set ears, smooth philtrum, and 
a thin and smooth upper lip.
Figure 2 Physical examination revealed a broad thumb.
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three-dimensional maximum intensity projection 
preconstruction and intravenous gadolinium-
enhancement revealed pachygyria, triphyllocephaly, 
septum pellucidum agenesis, azygous anterior cer-
ebral arterial holoprosencephaly (semi lobar type), 
and a brain infarction over the left anterior cere-
bral artery and middle cerebral artery watershed 
area. Spinal MR imaging revealed deformities of the 
sacrum and coccyx as well as caudal regression. 
Chest MR imaging identified a patent ductus arte-
riosus and a left-sided aortic arch with aberrant 
retroesophageal right subclavian artery. The infant 
died 41 days after birth due to cardiopulmonary 
failure. Chromosome and DNA analyses were nor-
mal, and the patient had a 46XX profile. DNA anal-
ysis did not reveal fibroblast growth factor receptor 
(FGFR)-1, FGFR2, FGFR3 or TWIST gene mutations.
3. Discussion
Birth defects are physical abnormalities present at 
birth, and 2−3% of all newborn infants have birth 
defects. Any substance that causes abnormal em-
bryonic or fetal development is a teratogen, and 
about 7% of all congenital birth defects are the 
result of teratogen exposure.
Most cases of craniosynostosis have no identi-
fied cause. Both holoprosencephaly and craniosyn-
ostosis are heterogeneous.30 The FGFRs are part of 
the tyrosine kinase family of genes that bind fi-
broblast growth factors and are involved in normal 
Figure 3 Physical examination revealed broad and 
medially deviated halluces.
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Figure 4 Cranial and facial three-dimensional computed tomography revealed lobulated skull contours with a clo-
verleaf shape, complete premature sagittal and bilateral lambdoid suture closures, and incomplete closure of the 
coronal sutures or triphyllocephaly.
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embryogenesis, growth and homeostasis.31 FGFR2 
(10q26) is expressed in the cranial sutures, and mu-
tations in this gene have been identified in Crouzon, 
Pfeiffer, Apert, and Jackson-Weiss syndromes.32 Mu-
tations in FGFR1 (8p11.2-p11.1) and FGFR3 (4p16.3) 
have been seen Pfeiffer syndrome cases.32 Mulliken 
et al33 performed genomic DNA analysis in 57 pa-
tients with bilateral coronal synostosis. They found 
a number of different mutations in FGFR1, FGFR2 
and FGFR3 in most patients. Only five patients with 
nonspecific brachycephaly did not show any muta-
tions in these genes. The detection rate was about 
97%. Plomp et al34 described five cases of Type 2 
Pfeiffer syndrome. Two of these patients showed the 
same mutation in the FGFR2 gene. One of the pa-
tients did not display any mutation. The DNA ana-
lyses of the other two patients were pending. The 
detection rate was about 67%. The TWIST (7p22-p21), 
which gene plays an essential role in cranial neural 
tube morphogenesis in mice,35 has been associated 
with Saethre-Chotzen syndrome, 36 and may func-
tion as an upstream FGFR regulator. 37
The present patient had no mutations in FGFRs 
or their upstream regulator reflexes. According to 
her unusual facial appearance, we made a differ-
ential diagnosis of Genoa syndrome, which exhibits 
holoprosencephaly and primary craniosynostosis. 
Our case had a thin upper lip and smooth philtrum, 
which were possibly caused by alcohol exposure. 
Pfeiffer syndrome may be a result of FGFR gene 
mutations and is also seen secondary to teratogen 
exposure (including smoking and alcohol). Several 
environmental factors have also been associated 
with isolated craniosynostosis. Results from a study 
by Alderman et al suggested that maternal smoking 
during the perinatal period significantly increased 
craniosynostosis risk.12 Kallen et al also reported an 
association between maternal smoking and sagittal 
craniosynostosis (odds ratio, 1.48; 95% confidence in-
terval, 1.02−2.14).38 However, Zeiger et al found no 
elevation in craniosynostosis risk with maternal 
smoking or vitamin usage. However, they did identify 
that the level of paternal education and alcohol 
consumption were risk factors for infant sagittal 
araniosynostosis.14
Maternal alcohol consumption during early 
pregnancy has been associated with holoprosen-
cephaly in offspring.4 Ronen and Andrews39 examined 
seven mothers of infants with holoprosencephaly 
and reported that three of these mothers had heavy 
alcohol consumption during early pregnancy.39 The 
birth of a child with cyclopia and agnathia to a se-
verely alcoholic mother was reported by Bonnemann 
and Meinecke,40 while Coulter et al41 described that 
the effects of fetal alcohol exposure included mid-
line cerebral dysgenesis and hypothalamic-pituitary 
dysfunction.41
4. Conclusions
Our case report described a newborn infant whose 
parents had risk factors of smoking and alcohol use 
in the prenatal period, and who presented with two 
unrelated birth defects. Therefore, we suspect that 
her craniosynostosis and holoprosencephaly were 
the result of teratogen exposure during the prena-
tal period.
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